Finance

Lists
Why is BOT down 20.00%?
Dive Deeper
BOT:ASX
Botanix Pharmaceuticals Ltd
AU$0.0080
-20.00%
(-0.0020) 1D
ኖቬም 20, 4:10:07 ከሰዓት ጂ ኤም ቲ+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
AU$0.01
High
AU$0.01
Low
AU$0.01
Mkt. cap
22.10 ሚ
Avg. vol.
11.07 ሚ
Volume
8.60 ሚ
52-wk high
AU$0.15
52-wk low
AU$0.01
EPS
-AU$0.03
Shares outstanding
2.76 ቢ
No. of employees
11
Open
AU$0.01
High
AU$0.01
Low
AU$0.01
Mkt. cap
22.10 ሚ
Avg. vol.
11.07 ሚ
Volume
8.60 ሚ
52-wk high
AU$0.15
52-wk low
AU$0.01
EPS
-AU$0.03
Shares outstanding
2.76 ቢ
No. of employees
11
News stories
From web sources and news partners
Barron's
Barron's
·
ከ35 ደቂቃዎች በፊት
S&P 500’s Tech Sector Crosses Bear Market Threshold
Investor's Business Daily
Investor's Business Daily
·
ከ1 ሰዓት በፊት
This VIX Signal Is Bullish For The S&P 500.
WSJ
WSJ
·
ከ8 ሰዓቶች በፊት
S&P 500 Flirts With Correction
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
27 ጁላይ 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
8.65 ሚ / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
8.25 ሚ
8.25 ሚ
8.65 ሚ
8.65 ሚ
Cost of goods sold
2.98 ሚ
2.98 ሚ
4.19 ሚ
4.19 ሚ
Cost of revenue
2.98 ሚ
2.98 ሚ
4.19 ሚ
4.19 ሚ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.32 ሚ
18.32 ሚ
19.70 ሚ
19.70 ሚ
Operating expense
22.08 ሚ
22.08 ሚ
22.30 ሚ
22.30 ሚ
Total operating expenses
25.06 ሚ
25.06 ሚ
26.49 ሚ
26.49 ሚ
Operating income
-16.81 ሚ
-16.81 ሚ
-17.85 ሚ
-17.85 ሚ
Other non operating income
683.30 ሺ
683.30 ሺ
109.28 ሺ
109.28 ሺ
EBT including unusual items
-16.60 ሚ
-16.60 ሚ
-18.29 ሚ
-18.29 ሚ
EBT excluding unusual items
-16.60 ሚ
-16.60 ሚ
-18.29 ሚ
-18.29 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.60 ሚ
-16.60 ሚ
-18.29 ሚ
-18.29 ሚ
Net profit margin
-201.11%
-201.11%
-211.46%
-211.46%
Earnings per share
-
-
-
-
Interest and investment income
352.66 ሺ
352.66 ሺ
202.18 ሺ
202.18 ሺ
Interest expense
-802.39 ሺ
-802.39 ሺ
-616.20 ሺ
-616.20 ሺ
Net interest expenses
-449.74 ሺ
-449.74 ሺ
-414.02 ሺ
-414.02 ሺ
Depreciation and amortization charges
593.18 ሺ
593.18 ሺ
565.11 ሺ
565.11 ሺ
EBITDA
-16.22 ሚ
-16.22 ሚ
-17.28 ሚ
-17.28 ሚ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች